The University of Chicago Header Logo

Connection

Ardaman Shergill to Pyridines

Back to Details
This is a "connection" page, showing publications Ardaman Shergill has written about Pyridines.
Ardaman Shergill
Connection Strength
0.093
Pyridines
  1. Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors. N Engl J Med. 2025 Feb 13; 392(7):653-665.
    View in: PubMed
    Score: 0.047
  2. Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. J Clin Oncol. 2024 Aug 20; 42(24):2918-2927.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.